Lack of interaction between ErbB2 and insulin receptor substrate signaling in breast cancer

被引：0
|
作者：
Susan M. Farabaugh
Bonita T. Chan
Xiaojiang Cui
Robert K. Dearth
Adrian V. Lee
机构：
[1] University of Pittsburgh Cancer Institute,Women’s Cancer Research Center, Department of Pharmacology and Chemical Biology
[2] Magee Women’s Research Institute,Lester and Sue Smith Breast Center, Department of Molecular and Cellular Biology
[3] Baylor College of Medicine,undefined
来源：
Cell Communication and Signaling | / 14卷
关键词：
IRS; ErbB2; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Lack of interaction between ErbB2 and insulin receptor substrate signaling in breast cancer
    Farabaugh, Susan M.
    Chan, Bonita T.
    Cui, Xiaojiang
    Dearth, Robert K.
    Lee, Adrian V.
    CELL COMMUNICATION AND SIGNALING, 2016, 14
  • [2] The ErbB2 signaling network as a target for breast cancer therapy
    Badache, Ali
    Goncalves, Anthony
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2006, 11 (01) : 13 - 25
  • [3] The ErbB2 Signaling Network as a Target for Breast Cancer Therapy
    Ali Badache
    Anthony Gonçalves
    Journal of Mammary Gland Biology and Neoplasia, 2006, 11 : 13 - 25
  • [4] A feedback loop between BEX2 and ErbB2 mediated by c-Jun signaling in breast cancer
    Naderi, Ali
    Liu, Ji
    Francis, Glenn D.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (01) : 71 - 82
  • [5] Flotillins as regulators of ErbB2 levels in breast cancer
    Pust, S.
    Klokk, T. I.
    Musa, N.
    Jenstad, M.
    Risberg, B.
    Erikstein, B.
    Tcatchoff, L.
    Liestol, K.
    Danielsen, H. E.
    van Deurs, B.
    Sandvig, K.
    ONCOGENE, 2013, 32 (29) : 3443 - 3451
  • [6] Treatment of ErbB2 breast cancer by mitochondrial targeting
    Sophia Eldad
    Rachel Hertz
    Gilad Vainer
    Ann Saada
    Jacob Bar-Tana
    Cancer & Metabolism, 8
  • [7] Treatment of ErbB2 breast cancer by mitochondrial targeting
    Eldad, Sophia
    Hertz, Rachel
    Vainer, Gilad
    Saada, Ann
    Bar-Tana, Jacob
    CANCER & METABOLISM, 2020, 8 (01)
  • [8] Flotillins as regulators of ErbB2 levels in breast cancer
    S Pust
    T I Klokk
    N Musa
    M Jenstad
    B Risberg
    B Erikstein
    L Tcatchoff
    K Liestøl
    H E Danielsen
    B van Deurs
    K Sandvig
    Oncogene, 2013, 32 : 3443 - 3451
  • [9] Prognosis in hormon receptor negative breast cancer patients according to ERBB2 status
    Dogan, L.
    Atalay, C.
    Yilmaz, K. B.
    Ozaslan, C.
    NEOPLASMA, 2008, 55 (06) : 544 - 548
  • [10] Identification of a small peptide that inhibits the phosphorylation of ErbB2 and proliferation of ErbB2 overexpressing breast cancer cells
    Pero, SC
    Shukla, GS
    Armstrong, AL
    Peterson, D
    Fuller, SP
    Godin, K
    Kingsley-Richards, SL
    Weaver, DL
    Bond, J
    Krag, DN
    INTERNATIONAL JOURNAL OF CANCER, 2004, 111 (06) : 951 - 960
12345